VANGUARD GROUP INC 13D and 13G filings for Actinium Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-29 12:10 pm Sale | 2025-06-30 | 13G | Actinium Pharmaceuticals, Inc. ATNM | VANGUARD GROUP INC | 1,371,840 4.390% | -253,160 (-15.58%) | Filing |
| 2024-11-12 1:33 pm Unchanged | 2024-09-30 | 13G | Actinium Pharmaceuticals, Inc. ATNM | VANGUARD GROUP INC | 1,625,000 5.210% | 0 (Unchanged) | Filing |
| 2024-11-04 11:47 am Unchanged | 2024-09-30 | 13G | Actinium Pharmaceuticals, Inc. ATNM | VANGUARD GROUP INC | 1,625,000 5.210% | 0 (Unchanged) | Filing |
| 2024-11-04 11:10 am Purchase | 2024-09-30 | 13G | Actinium Pharmaceuticals, Inc. ATNM | VANGUARD GROUP INC | 1,625,000 5.210% | 1,625,000 (New Position) | Filing |